NS3728 is an orally active chloride channel blocker for the treatment of cancer.
NS3728 is an orally active chloride channel blocker for the treatment of cancer.
Investigated for use/treatment in anemia (sickle cell) and cancer/tumors (unspecified).
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.